Clinical trials recruiting for IgA Nephropathy
8
Recruiting trials
28
US states with sites
8
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 3 |
| Connecticut | 2 |
| Florida | 2 |
| Missouri | 2 |
| Ohio | 2 |
| Texas | 2 |
| Alabama | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Illinois | 1 |
| Indiana | 1 |
Top cities
Lawrenceville, Georgia 3Houston, Texas 2Orlando, Florida 2Albuquerque, New Mexico 1Augusta, Georgia 1Aurora, Colorado 1Austell, Georgia 1Baltimore, Maryland 1Birmingham, Alabama 1Boca Raton, Florida 1
Self-screener
Recruiting trials
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
- KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
- National Registry of Rare Kidney Diseases
- Nefecon and Ambrisentan in IgA Nephropathy
- Study of BHV-1400 in IgA Nephropathy
- Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
Related conditions
Trials recruiting for IgA Nephropathy often also study these conditions. Each links to its own recruiting-trial list.
Chronic kidney disease 588Membranous Nephropathy 3Lupus 332Focal Segmental Glomerulosclerosis 3Vasculitis 7Type 2 diabetes 891Tuberous Sclerosis 10Sickle Cell Nephropathy 3Sickle cell disease 172Renal Insufficiency, Chronic 19
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for IgA Nephropathy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.